Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk

Dow Jones2025-04-15

1414 ET - Life sciences and diagnostic tools companies are primed for surprisingly good 1Qs amid positive pre-announcements from Pacific Biosciences of California, Qiagen NV and Bruker, but don't fall for the initial positive news, Bank of America analysts say in a research note. "We wouldn't overreact to these initial prints," the analysts say, adding headwinds from National Institutes of Health budget cuts, tariffs and a trade war with China only materialized recently, giving companies one to two months of regular business activity in the 1Q. The real risk, then, lies in 2Q/3Q and the rest of FY25, the analysts say. They expect softer commentary particularly from academic and government exposed companies like Illumina, 10x Genomics and others, while diagnostics companies are likely a safer bet, they say. (kelly.cloonan@wsj.com)

(END) Dow Jones Newswires

April 14, 2025 14:14 ET (18:14 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2527114687?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-15 02:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527114687","market":"sg","top_or_hot":-1,"title":"Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1414 ET - Life sciences and diagnostic tools companies are primed for surprisingly good 1Qs amid positive pre-announcements from Pacific Biosciences of California, Qiagen NV and Bruker, but don't fall for the initial positive news, Bank of America analysts say in a research note. \"We wouldn't overreact to these initial prints,\" the analysts say, adding headwinds from National Institutes of Health budget cuts, tariffs and a trade war with China only materialized recently, giving companies one to two months of regular business activity in the 1Q. The real risk, then, lies in 2Q/3Q and the rest of FY25, the analysts say. They expect softer commentary particularly from academic and government exposed companies like <a href=\"https://laohu8.com/S/ILMN\">Illumina</a>, 10x Genomics and others, while diagnostics companies are likely a safer bet, they say. (kelly.cloonan@wsj.com) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 14:14 ET (18:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLife Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-15 02:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1414 ET - Life sciences and diagnostic tools companies are primed for surprisingly good 1Qs amid positive pre-announcements from Pacific Biosciences of California, Qiagen NV and Bruker, but don't fall for the initial positive news, Bank of America analysts say in a research note. \"We wouldn't overreact to these initial prints,\" the analysts say, adding headwinds from National Institutes of Health budget cuts, tariffs and a trade war with China only materialized recently, giving companies one to two months of regular business activity in the 1Q. The real risk, then, lies in 2Q/3Q and the rest of FY25, the analysts say. They expect softer commentary particularly from academic and government exposed companies like <a href=\"https://laohu8.com/S/ILMN\">Illumina</a>, 10x Genomics and others, while diagnostics companies are likely a safer bet, they say. (kelly.cloonan@wsj.com) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 14:14 ET (18:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2125909247.SGD","symbol_name":"Natixis Thematics Meta H-R/A SGD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527114687","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527114687","pubTimestamp":1744654440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1414 ET - Life sciences and diagnostic tools companies are primed for surprisingly good 1Qs amid positive pre-announcements from Pacific Biosciences of California, Qiagen NV and Bruker, but don't fall for the initial positive news, Bank of America analysts say in a research note. \"We wouldn't overreact to these initial prints,\" the analysts say, adding headwinds from National Institutes of Health budget cuts, tariffs and a trade war with China only materialized recently, giving companies one to two months of regular business activity in the 1Q. The real risk, then, lies in 2Q/3Q and the rest of FY25, the analysts say. They expect softer commentary particularly from academic and government exposed companies like Illumina, 10x Genomics and others, while diagnostics companies are likely a safer bet, they say. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","ILMN":"Illumina","BK4121":"生命科学工具和服务","QGEN":"快而精医药","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","BK4534":"瑞士信贷持仓","PACB":"Pacific Biosciences of Californi","BK4585":"ETF&股票定投概念","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BRKR":"布鲁克","LU1861558580.USD":"日兴方舟颠覆性创新基金B","BK4535":"淡马锡持仓","TXG":"10x Genomics, Inc.","BK4548":"巴美列捷福持仓","BK4588":"碎股"},"translate_title":"生命科学公司可能会看到令人惊讶的良好第一季度业绩——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":0.9,"ILMN":0.9,"BRKR":0.9,"QGEN":0.9,"PACB":0.9},"content_text":"1414 ET - Life sciences and diagnostic tools companies are primed for surprisingly good 1Qs amid positive pre-announcements from Pacific Biosciences of California, Qiagen NV and Bruker, but don't fall for the initial positive news, Bank of America analysts say in a research note. \"We wouldn't overreact to these initial prints,\" the analysts say, adding headwinds from National Institutes of Health budget cuts, tariffs and a trade war with China only materialized recently, giving companies one to two months of regular business activity in the 1Q. The real risk, then, lies in 2Q/3Q and the rest of FY25, the analysts say. They expect softer commentary particularly from academic and government exposed companies like Illumina, 10x Genomics and others, while diagnostics companies are likely a safer bet, they say. (kelly.cloonan@wsj.com) \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 14:14 ET (18:14 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2527114687","isCrawlerRequest":true}